Locally Advanced Breast Cancer (LABC)
Also known as:Locally Advanced Breast Cancer/Locally Advance Breast Cancer (LABC)/Malignant neoplasm of breast/Malignant breast neoplasm/Breast cancer/Breast tumor malignant/Breast tumour malignant/Breast cancer NOS/Breast cancer stage unspecified/Ca breast
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB01217 | Anastrozole | 竞争、选择性非甾体类芳香化酶inhibitor used as adjuvant therapy for the treatment of hormone receptor-positive breast cancer in postmenopausal women. |
| DB01248 | Docetaxel | A taxoid antineoplastic agent used in the treatment of various cancers, such as locally advanced or metastatic breast cancer, metastatic prostate cancer, gastric adenocarcinoma, and head and neck cancer. |
| DB06205 | Hyaluronidase (human recombinant) | An enzyme used to improve the absorption and dispersion of parenterally administered fluids, drugs, and contrast agents. |
| DB04845 | Ixabepilone | A microtubule inhibitor administered in combination with capecitabine or alone in the treatment of metastatic or locally advanced breast cancer that has shown inadequate response to taxanes and anthracyclines. |
| DB09074 | Olaparib | A poly (ADP-ribose) polymerase (PARP) inhibitor used to treat ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer. |
| DB06366 | Pertuzumab | An antineoplastic agent used in the treatment of HER2-positive metastatic breast cancer in combination with other antineoplastic agents. |
| DB11760 | Talazoparib | A poly-ADP ribose polymerase inhibitor used to treat HER2-, BRCA mutated locally advanced or metastatic breast cancer. |
| DB00072 | Trastuzumab | A monoclonal anti-human epidermal growth factor receptor 2 protein antibody used to treat HER2-positive breast, gastroesophageal, and gastric cancers. |